Tri Locum Partners LP Makes New $14.22 Million Investment in UnitedHealth Group Incorporated (NYSE:UNH)

Tri Locum Partners LP acquired a new stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 28,115 shares of the healthcare conglomerate's stock, valued at approximately $14,222,000. UnitedHealth Group accounts for about 2.9% of Tri Locum Partners LP's investment portfolio, making the stock its 16th biggest holding.

Other large investors have also recently added to or reduced their stakes in the company. Geode Capital Management LLC grew its stake in UnitedHealth Group by 1.6% during the 4th quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate's stock worth $10,068,869,000 after purchasing an additional 319,515 shares in the last quarter. Capital International Investors raised its holdings in UnitedHealth Group by 6.2% in the fourth quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate's stock valued at $7,899,905,000 after acquiring an additional 906,365 shares in the last quarter. Norges Bank acquired a new position in UnitedHealth Group during the 4th quarter worth approximately $6,375,744,000. Franklin Resources Inc. raised its holdings in shares of UnitedHealth Group by 10.7% in the 4th quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate's stock valued at $4,514,178,000 after purchasing an additional 861,854 shares in the last quarter. Finally, Bank of New York Mellon Corp grew its stake in shares of UnitedHealth Group by 0.5% during the fourth quarter. Bank of New York Mellon Corp now owns 7,931,478 shares of the healthcare conglomerate's stock worth $4,012,218,000 after purchasing an additional 36,394 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on UNH shares. Truist Financial dropped their price objective on UnitedHealth Group from $660.00 to $580.00 and set a "buy" rating on the stock in a report on Monday, April 21st. Argus cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Monday, April 21st. Oppenheimer cut their price target on shares of UnitedHealth Group from $640.00 to $600.00 and set an "outperform" rating on the stock in a research note on Monday, April 21st. Piper Sandler dropped their price objective on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a report on Thursday, January 2nd. Finally, Cantor Fitzgerald reaffirmed an "overweight" rating and set a $700.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Three investment analysts have rated the stock with a hold rating, nineteen have given a buy rating and three have given a strong buy rating to the company. According to data from MarketBeat, the company presently has an average rating of "Buy" and a consensus price target of $596.86.

UnitedHealth Group Price Performance

NYSE UNH traded down $11.37 during mid-day trading on Thursday, hitting $400.07. The stock had a trading volume of 9,282,415 shares, compared to its average volume of 4,563,807. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The company has a market cap of $364.15 billion, a price-to-earnings ratio of 25.81, a P/E/G ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a 52-week low of $399.68 and a 52-week high of $630.73. The company has a 50 day simple moving average of $498.51 and a 200 day simple moving average of $531.25.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same period in the previous year, the company posted $6.91 earnings per share. Equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 2.10%. UnitedHealth Group's dividend payout ratio (DPR) is 35.18%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.